ZIMVV ZIMVIE INC

ZimVie to Report Third Quarter Financial Results on October 30, 2024

ZimVie to Report Third Quarter Financial Results on October 30, 2024

PALM BEACH GARDENS, Fla., Oct. 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the third quarter 2024 after market close on Wednesday, October 30, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Those interested in listening to the conference call should . Participants are encouraged to register more than 15 minutes before the start of the call. A replay of the webcast will be available at

About ZimVie

ZimVie is a global life sciences leader in the dental market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm Beach Gardens, Florida, and additional facilities around the globe, ZimVie works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including trusted dental implants, biomaterials, and digital workflow solutions. As a worldwide leader in this space, ZimVie is committed to advancing clinical science and technology foundational to restoring daily life. For more information about ZimVie, please visit us at . Follow @ZimVie on , , , or .

Media Contact Information:

ZimVie

Grace Flowers •

(561) 319-6130

Investor Contact Information:

Gilmartin Group LLC

Marissa Bych •



EN
16/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ZIMVIE INC

 PRESS RELEASE

ZimVie Reports Third Quarter 2024 Financial Results

ZimVie Reports Third Quarter 2024 Financial Results Third Party Net Sales from Continuing Operations of $103.2 millionNet Loss from Continuing Operations of $(3.0) million; Net Loss margin of (3.0%) Adjusted EBITDA[1] from Continuing Operations of $13.1 million; Adjusted EBITDA[1] margin of 12.7%GAAP diluted EPS from Continuing Operations of $(0.11) and adjusted diluted EPS of $0.12 PALM BEACH GARDENS, Fla., Oct. 30, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter ended September 30,...

 PRESS RELEASE

ZimVie to Present at the UBS Global Healthcare Conference

ZimVie to Present at the UBS Global Healthcare Conference PALM BEACH GARDENS, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming UBS Global Healthcare Conference. Management will be presenting on Tuesday, November 12, 2024 at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time. A live webcast of the event, as well as an archived recording will be available on ZimVie’s investor website at . About ZimVieZimVie is a global life sciences leader in the dental market t...

 PRESS RELEASE

ZimVie to Report Third Quarter Financial Results on October 30, 2024

ZimVie to Report Third Quarter Financial Results on October 30, 2024 PALM BEACH GARDENS, Fla., Oct. 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the third quarter 2024 after market close on Wednesday, October 30, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should . Participants are encouraged to register more than 15 minutes before the start of the call. A repla...

 PRESS RELEASE

ZimVie Reports Second Quarter 2024 Financial Results

ZimVie Reports Second Quarter 2024 Financial Results Third Party Net Sales from Continuing Operations of $116.8 millionNet Loss from Continuing Operations of $(9.6) million; Net Loss margin of (8.2%) Adjusted EBITDA[1] from Continuing Operations of $16.1 million; Adjusted EBITDA[1] margin of 13.8%Reduced debt to $235.1 million, ended quarter with cash balance from Continuing Operations of $78.6 million PALM BEACH GARDENS, Fla., Aug. 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter...

 PRESS RELEASE

ZimVie Announces the Release of RealGUIDE® 5.4 Software Update

ZimVie Announces the Release of RealGUIDE® 5.4 Software Update Latest Update for ZimVie’s RealGUIDE® Dental Implant Software Suite Introduces New Features to Drive Provider Efficiency and Savings PALM BEACH GARDENS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced the release of its RealGUIDE® 5.4 software. The update is now available in all markets where RealGUIDE is sold, enhancing ZimVie’s current RealGUIDE software suite for treatment planning and implant restoration. RealGUIDE 5.4 now helps ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch